Toll-like receptor-1, -2, and -6 genotypes in relation to salivary human beta-defensin-1, -2, -3 and human neutrophilic peptide-1.


Journal

Journal of clinical periodontology
ISSN: 1600-051X
Titre abrégé: J Clin Periodontol
Pays: United States
ID NLM: 0425123

Informations de publication

Date de publication:
11 2022
Historique:
revised: 07 06 2022
received: 28 01 2022
accepted: 06 07 2022
pubmed: 12 7 2022
medline: 19 10 2022
entrez: 11 7 2022
Statut: ppublish

Résumé

To examine whether functional gene polymorphisms of toll-like receptor (TLR)1, TLR2, and TLR6 are related to the salivary concentrations of human beta-defensins (hBDs)-1, -2, -3, and human neutrophilic peptide (HNP)-1. Polymorphisms of TLR1 (rs5743618), TLR2 (rs5743708), and TLR6 (rs5743810) were genotyped by PCR-based pyrosequencing from the salivary samples of 230 adults. Salivary hBD-1, -2, -3, and HNP-1 concentrations were measured using enzyme-linked immunosorbent assay. General and periodontal health examinations, including panoramic radiography, were available for all participants. The genotype frequencies for wild types and variant types were as follows: 66.5% and 33.5% for TLR1, 95.5% and 4.5% for TLR2, and 25.1% and 74.9% for TLR6, respectively. The TLR2 heterozygote variant group exhibited higher salivary hBD-2 concentrations than the TLR2 wild-type group (p = .038). On the contrary, elevated hBD-2 concentrations were detected in the TLR6 wild-type group compared with the TLR6 heterozygote and homozygote variant group (p = .028). The associations between TLR6 genotypes and salivary hBD-2 concentrations remained significant after adjusting them for periodontal status, age, and smoking. hBD-2 concentrations in saliva are related to TLR2 and TLR6 polymorphisms, but only the TLR6 genotype seems to exhibit an independent association with the salivary hBD-2 concentrations.

Identifiants

pubmed: 35817420
doi: 10.1111/jcpe.13697
pmc: PMC9796255
doi:

Substances chimiques

Toll-Like Receptor 1 0
Toll-Like Receptor 2 0
Toll-Like Receptor 6 0
alpha-Defensins 0
beta-Defensins 0
human neutrophil peptide 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1185-1191

Subventions

Organisme : Academy of Finland
Organisme : Suomen Hammaslääkäriseura Apollonia

Informations de copyright

© 2022 The Authors. Journal of Clinical Periodontology published by John Wiley & Sons Ltd.

Références

J Clin Periodontol. 2022 Nov;49(11):1185-1191
pubmed: 35817420
Front Immunol. 2012 Apr 18;3:79
pubmed: 22566960
PLoS One. 2011;6(10):e26198
pubmed: 22022564
Acta Paediatr. 2013 Dec;102(12):1160-4
pubmed: 24112285
Curr Issues Mol Biol. 2005 Jul;7(2):119-33
pubmed: 16053246
J Periodontal Res. 2017 Jun;52(3):540-545
pubmed: 27624657
J Innate Immun. 2009;1(4):350-7
pubmed: 20375592
PLoS Genet. 2009 Jul;5(7):e1000562
pubmed: 19609346
Infect Immun. 2016 Apr 22;84(5):1446-1456
pubmed: 26930710
J Periodontol. 2013 Jan;84(1):126-33
pubmed: 22443519
Infect Immun. 2009 Mar;77(3):1044-52
pubmed: 19103770
Dis Markers. 2020 Aug 06;2020:9353958
pubmed: 32831974
Auris Nasus Larynx. 2018 Aug;45(4):753-759
pubmed: 29500040
PLoS One. 2016 Oct 11;11(10):e0164075
pubmed: 27727278
Semin Cell Dev Biol. 2019 Apr;88:163-172
pubmed: 29501617
J Innate Immun. 2017;9(4):375-386
pubmed: 28241127
Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S421-6
pubmed: 16237641
J Clin Periodontol. 2013 Jan;40(1):18-25
pubmed: 23078613
J Immunol. 2004 Nov 1;173(9):5398-405
pubmed: 15494486
Acta Odontol Scand. 2020 Jul;78(5):327-331
pubmed: 31980002
J Dent Res. 2006 Jun;85(6):524-9
pubmed: 16723649
J Oral Microbiol. 2012;4:
pubmed: 22389759
J Clin Periodontol. 2020 Mar;47(3):309-318
pubmed: 31799742
Front Immunol. 2019 Feb 14;10:208
pubmed: 30837987
Biochem Soc Trans. 2007 Dec;35(Pt 6):1445-8
pubmed: 18031242
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1871-1876
pubmed: 27492306
Periodontol 2000. 2021 Jun;86(1):188-200
pubmed: 33690934
J Clin Periodontol. 2016 Oct;43(10):807-15
pubmed: 27191801

Auteurs

Mervi Gürsoy (M)

Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Welfare Division, Oral Health Care, Turku, Finland.

Eija Könönen (E)

Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.

Qiushui He (Q)

Research Center for Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.
InFLAMES Research Flagship Centre, University of Turku, Turku, Finland.

Anna Liukkonen (A)

Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.

Sisko Huumonen (S)

Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland.

Ulvi Kahraman Gürsoy (UK)

Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH